Effect of Rifampin on the Pharmacokinetics of BAY73-4506
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2011 |
| End Date: | May 2011 |
A Phase 1, Non-Randomized, Open Label Study to Determine the Effect of Rifampin on the Pharmacokinetics of a Single Oral Dose of 160 mg Regorafenib (BAY73-4506) in Healthy Volunteers
The purpose of this study is to see if giving rifampin, a marketed antibiotic, changes how
your body absorbs and distributes BAY73-4506.
We found this trial at
1
site
Click here to add this to my saved trials
